The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics
Abstract
Epidermal growth factor receptor (ErbB1, EGFR) is overexpressed in a variety of human cancer cells. It has been considered as a rational target for drug delivery. To identify novel ligands with specific binding capabilities to EGFR, we screened a phage display peptide library and found an enriched phage clone encoding the amino acid sequence YHWYGYTPQNVI (designated as GE11). Competitive binding assay and Scatchard analysis revealed that GE11 peptide bound specifically and efficiently to EGFR with a dissociation constant of ∼22 nM, but with much lower mitogenic activity than with EGF. We showed that the peptides were internalized preferentially into EGFR highly expressing cells, and they accumulated in EGFR overexpressing tumor xenografts after i.v. delivery in vivo. In gene delivery studies, GE11‐conjugated polyethylenimine (PEI) vectors were less mitogenic, but still quite efficient at transfecting genes into EGFR highly expressing cells and tumor xenografts. Taken together, GE11 is a potentially safe and efficient targeting moiety for selective drug delivery systems mediated through EGFR.—Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., Gu, J. Identification and characterization of a novel peptide ligand of epidermal growth factor receptor for targeted delivery of therapeutics. FASEB J. 19, 1978–1985 (2005)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hansen, M. B., Nielsen, S. E., & Berg, K. (1989) · Journal of Immunological Methods · doi:10.1016/0022-1759(89)90397-9 · Cited by 3,507
Epidermal growth factor-related peptides and their receptors in human malignancies
Salomon, D. S., Brandt, R., Ciardiello, F., & Normanno, N. (1995) · Critical Reviews in Oncology/Hematology · doi:10.1016/1040-8428(94)00144-i · Cited by 2,690
Crystal Structure of the Complex of Human Epidermal Growth Factor and Receptor Extracellular Domains
Ogiso, H., Ishitani, R., Nureki, O., Fukai, S., Yamanaka, M., Kim, J.-H., Saito, K., Sakamoto, A., Inoue, M., Shirouzu, M., et al. (2002) · Cell · doi:10.1016/s0092-8674(02)00963-7 · Cited by 1,227
The Epidermal Growth Factor Receptor and Its Inhibition in Cancer Therapy
Woodburn, J. R. (1999) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00045-x · Cited by 827
Efficient Gene Transfer Using Reversibly Cross-Linked Low Molecular Weight Polyethylenimine
Gosselin, M. A., Guo, W., & Lee, R. J. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0100455 · Cited by 454
Lee, E. R., Marshall, J., Siegel, C. S., Jiang, C., Yew, N. S., Nichols, M. R., Nietupski, J. B., Ziegler, R. J., Lane, M. B., Wang, K. X., et al. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1701 · Cited by 443
Kursa, M., Walker, G. F., Roessler, V., Ogris, M., Roedl, W., Kircheis, R., & Wagner, E. (2003) · Bioconjugate Chemistry · doi:10.1021/bc0256087 · Cited by 310
Identification of a peptide blocking vascular endothelial growth factor (VEGF)-mediated angiogenesis
Binetruy-Tournaire, R. (2000) · The EMBO Journal · doi:10.1093/emboj/19.7.1525 · Cited by 295
(2004) · The Women's Oncology Review · doi:10.3109/14733400410001727592 · Cited by 288
Blessing, T., Kursa, M., Holzhauser, R., Kircheis, R., & Wagner, E. (2001) · Bioconjugate Chemistry · doi:10.1021/bc0001488 · Cited by 245
Integrin targeting using RGD‐PEI conjugates for in vitro gene transfer
Kunath, K., Merdan, T., Hegener, O., Häberlein, H., & Kissel, T. (2003) · The Journal of Gene Medicine · doi:10.1002/jgm.382 · Cited by 231
A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene Delivery
Solodin, I., Brown, C. S., Bruno, M. S., Chow, C.-Y., Jang, E.-H., Debs, R. J., & Heath, T. D. (1995) · Biochemistry · doi:10.1021/bi00041a033 · Cited by 189
Halin, C., Gafner, V., Villani, M. E., Borsi, L., Berndt, A., Kosmehl, H., Zardi, L., & Neri, D. (2003) · PubMed · Cited by 168
Rajotte, D., & Ruoslahti, E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.17.11593 · Cited by 166
Opresko, L. K., Chang, C.-P., Will, B. H., Burke, P. M., Gill, G. N., & Wiley, H. S. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.9.4325 · Cited by 147
Chiu, S.-J., Ueno, N. T., & Lee, R. J. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.03.019 · Cited by 146
Radiolabelled peptides for tumour therapy: current status and future directions
de Jong, M., Kwekkeboom, D. J., Valkema, R., & Krenning, E. P. (2003) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-002-1107-8 · Cited by 132
Structural and functional analysis of cationic transfection lipids: the hydrophobic domain.
Balasubramaniam, R. P., Bennett, M. J., Aberle, A. M., Malone, J. G., Nantz, M. H., & Malone, R. W. (1996) · PubMed · Cited by 123
Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody
Li, S., Tan, Y., Viroonchatapan, E., Pitt, B. R., & Huang, L. (2000) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.2000.278.3.l504 · Cited by 122
Specific systemic nonviral gene delivery to human hepatocellular carcinoma xenografts in SCID mice
Wolschek, M. F., Thallinger, C., Kursa, M., Roessler, V., Allen, M., Lichtenberger, C., Kircheis, R., Lucas, T., Willheim, M., Reinisch, W., et al. (2002) · Hepatology · doi:10.1053/jhep.2002.36372 · Cited by 114
Peptides as Carrier for Tumor Diagnosis and Treatment
Langer, M., & Beck‐Sickinger, A. G. (2001) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1568011013354877 · Cited by 104
Identification of Peptides That Target the Endothelial Cell–Specific LOX-1 Receptor
White, S. J., Nicklin, S. A., Sawamura, T., & Baker, A. H. (2001) · Hypertension · doi:10.1161/01.hyp.37.2.449 · Cited by 61
Development of cationic liposome formulations for intratracheal gene therapy of early lung cancer
Zou, Y., Zong, G., Ling, Y., & Perez-Soler, R. (2000) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700156 · Cited by 59
Incorporation of Reversibly Cross-Linked Polyplexes into LPDII Vectors for Gene Delivery
Gosselin, M. A., Guo, W., & Lee, R. J. (2002) · Bioconjugate Chemistry · doi:10.1021/bc025512c · Cited by 54
Cited by
Systemically Injected Exosomes Targeted to EGFR Deliver Antitumor MicroRNA to Breast Cancer Cells
Ohno, S.-I., Takanashi, M., Sudo, K., Ueda, S., Ishikawa, A., Matsuyama, N., Fujita, K., Mizutani, T., Ohgi, T., Ochiya, T., et al. (2013) · Molecular Therapy · doi:10.1038/mt.2012.180 · Cited by 1,666
Nicolas, J., Mura, S., Brambilla, D., Mackiewicz, N., & Couvreur, P. (2013) · Chem. Soc. Rev. · doi:10.1039/c2cs35265f · Cited by 1,270
Exosomes: Therapy delivery tools and biomarkers of diseases
Barile, L., & Vassalli, G. (2017) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2017.02.020 · Cited by 1,038
Gelatin-based nanoparticles as drug and gene delivery systems: Reviewing three decades of research
Elzoghby, A. O. (2013) · Journal of Controlled Release · doi:10.1016/j.jconrel.2013.09.019 · Cited by 651
Epidermal growth factor receptor targeting in cancer: a review of trends and strategies
Yewale, C., Baradia, D., Vhora, I., Patil, S., & Misra, A. (2013) · Biomaterials · doi:10.1016/j.biomaterials.2013.07.100 · Cited by 533
Metadata
- Authors
- Li, Z., Zhao, R., Wu, X., Sun, Y., Yao, M., Li, J., Xu, Y., & Gu, J.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2005-12
- Volume
- 19
- Issue
- 14
- Pages
- 1978-1985
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2081477031
- Cited by
- 419
- References
- 25
- FWCI
- 1.98
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.